Japanese researchers identify biological cause of long COVID brain fog

Scientists in Japan have discovered a key molecular change behind the brain fog experienced by many long COVID patients. Using advanced brain imaging, they found increased density of AMPA receptors linked to cognitive impairment. The findings, published on October 1, 2025, could lead to new diagnostics and treatments.

Spotlight on tardive dyskinesia and its management

October 02, 2025 Reported by AI

Tardive dyskinesia remains a significant side effect for patients on long-term antipsychotic medications. Recent medical discussions highlight its symptoms, causes, and emerging treatments. Awareness efforts aim to improve early detection and intervention.

Blood test identifies Parkinson's years before symptoms

October 03, 2025 Reported by AI

Scientists have developed a blood-based test that detects Parkinson's disease up to seven years before the onset of symptoms. The test targets abnormal alpha-synuclein proteins and shows high accuracy in at-risk individuals. This breakthrough could enable earlier treatments to slow disease progression.

Alzheimer's Biomarker Tests Development

Regulatory developments were noted for blood-based biomarker tests to detect Alzheimer's disease. These tests represent an emerging tool for early diagnosis. The update was part of a health innovation brief.